BioPlus Acquisition Corp. Contracts & Agreements
27 Contracts & Agreements
- Business Finance (19 contracts)
- Business Operations (1)
- Mergers & Acquisitions (1)
- Uncategorized (6)
- Termination and Release Agreement, dated October 4, 2023, by and among BioPlus Acquisition Corp., Guardian Merger Subsidiary Corp., Avertix Medical, Inc., and BioPlus Sponsor LLC (Filed With SEC on October 4, 2023)
- Promissory Note issued to BioPlus Sponsor LLC (Filed With SEC on June 8, 2023)
- Description of Registered Securities (Filed With SEC on March 11, 2022)
- Sponsor Loan Note, dated December 2, 2021, issued by the Company to the Sponsor (Filed With SEC on December 8, 2021)
- Administrative Services Agreement, dated December 2, 2021, by and between the Company and First In Line Enterprises, Inc (Filed With SEC on December 8, 2021)
- A Form of Unit Subscription Agreement, dated December 2, 2021, by and between the Company and the representatives of the underwriters (Filed With SEC on December 8, 2021)
- Unit Subscription Agreement, dated December 2, 2021, by and between the Company and BioPlus Sponsor LLC (Filed With SEC on December 8, 2021)
- Registration Rights Agreement, dated December 2, 2021, by and among the Company and certain security holders (Filed With SEC on December 8, 2021)
- Investment Management Trust Agreement, December 2, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on December 8, 2021)
- Letter Agreement, dated December 2, 2021, by and among the Company, its officers, directors, and BioPlus Sponsor LLC (Filed With SEC on December 8, 2021)
- Warrant Agreement, dated December 2, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on December 8, 2021)
- Underwriting Agreement, dated December 2, 2021, by and among the Company and Cantor Fitzgerald & Co (Filed With SEC on December 8, 2021)
- Form of Administrative Support Agreement by and between the Registrant and First In Line Enterprises, Inc (Filed With SEC on November 29, 2021)
- Form of Sponsor Loan Note to be issued at closing of the initial public offering (Filed With SEC on November 29, 2021)
- Form of Indemnity Agreement (Filed With SEC on November 29, 2021)
- Form of Placement Unit Purchase Agreement between the Registrant and Cantor Fitzgerald & Co (Filed With SEC on November 29, 2021)
- Form of Placement Unit Purchase Agreement between the Registrant and BioPlus Sponsor LLC (Filed With SEC on November 29, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant (Filed With SEC on November 29, 2021)
- Form of Letter Agreement among the Registrant and our officers, directors and BioPlus Sponsor LLC (Filed With SEC on November 29, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant (Filed With SEC on November 29, 2021)
- Specimen Warrant Certificate (Filed With SEC on November 29, 2021)
- Specimen Class A Ordinary Share Certificate (Filed With SEC on November 29, 2021)
- Specimen Unit Certificate (Filed With SEC on November 29, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 29, 2021)
- Promissory Note, dated March 18, 2021, issued to BioPlus Sponsor, LLC (Filed With SEC on July 20, 2021)
- Securities Subscription Agreement, dated March 18, 2021, between the Registrant and BioPlus Sponsor LLC (Filed With SEC on July 20, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on July 20, 2021)